GlobalData predicts the gMG market will grow from $6.1bn in 2024 to $10.5bn in 2034, with J&J's Imaavy set to bring in more than $300m in sales.

The post J&J’s Imaavy shows two-year benefit in gMG appeared first on Clinical Trials Arena.